The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)

CompletedOBSERVATIONAL
Enrollment

584

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Coronary Artery Disease
Trial Locations (15)

8200

Aarhus University Hospital Skejby, Aarhus

20154

Centro Cardiologico Monzino, Milan

27705

Duke University Clinical Research Institution, Durham

29609

CHU Brest - Hopital de Cardiologie, Brest

55131

Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz

69677

Cardiovascular Hospital -Interventional Cardiology Dept, Hospices Civils de Lyon and Claude Bernard University France, Lyon

80636

Deutsches Herzzentrum München - ISAResearch Centre, Munich

94063

HeartFlow, Inc, Redwood City

94305

Stanford University, Stanford

A-8020

LKH-GRAZ-West - Department of Cardiology, Graz

A-6020

Innsbruck Medical University, Department of Radiology II, Innsbruck

Unknown

Cardiovascular Center Aalst, Aalst

04289

Heart Center Leipzig GmbH, Leipzig

NE7 7DN

Freeman Hospital - Therapeutics & Cardiac Research Team, Newcastle upon Tyne

SO16 6YD

University Hospital Southampton NHS Foundation Trust, Southampton

Sponsors
All Listed Sponsors
collaborator

Duke Clinical Research Institute

OTHER

lead

HeartFlow, Inc.

INDUSTRY